CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...